| |
|
| |
|
| |
|
|
Aortx
AorTx, Inc. (previously CardiacMD) is developing device solutions that rapidly convert aortic valve replacement to a minimally invasive,
percutaneous, approach. AorTx is developing devices that cover the entire procedural solution for percutaneous heart valve therapy--
from the implant itself to delivery and deployment of the valve.
Acquired by Hansen Medical November 2007.
|
| |
|
| |
|
| |
|
|
Asthmatx
Asthmatx is developing an interventional medical device for the bronchoscopic treatment of patients with moderate to severe asthma.
http://www.asthmatx.com/
|
| |
|
| |
|
| |
|
Atrionix, Inc.
|
Atrionix
Developing a minimally invasive cather based treatment for atrial fibrillation.
Acquired by Johnson & Johnson January 2001.
|
| |
|
| |
|
| |
|
|
Axis Surgical Technologies, Inc.
Axis Surgical Technologies, Inc. was founded to develop, manufacture, and market
innovative devices that improve quality and efficiency in spinal surgery,
especially for minimally invasive surgical techniques. Axis offers a powerful,
novel integration of visualization and articulation capabilities that will
ultimately provide a strong, sustainable competitive advantage in this market.
|
| |
|
| |
|
| |
|
|
Bacchus Vascular, Inc.
Therapeutic devices to treat vascular obstructions.
Acquired by Coviden March 2009.
3110 Coronado Drive
Santa Clara, CA 95054
Tel: 408.980.8300
http://bacchusvascular.com
|
| |
|
| |
|
| |
|
Bio Interventional Inc.
|
Bio Interventional Inc.
Developing products to facilitate hemostasis at the fermoral ateriotomy site created during diagnostic angiogram procedures.
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
Broncus Technologies
Broncus Technologies is a medical technology company focused on developing
minimally-invasive medical devices for lung diseases, including lung cancer and
emphysema.
|
| |
|
| |
|
| |
|
|
Cardiovascular Systems, Inc.
CSI is a progressive company that is redefining interventional vascular solutions
by providing minimally invasive products, including the Diamondback 360°
system to remove resistant, non-compliant blockages in arteries to change vessel
compliance and restore blood flow.
http://www.csi360.com/
|
| |
|
| |
|
| |
|
|
Catharos Medical Systems, Inc.
Catharos is developing a proprietary aspiration capturing system.
|
| |
|
| |
|
| |
|
|
Converge Medical, Inc.
Develops novel medical devices designed to enable surgeons to perform faster, less invasive surgery
utilizing suchureless vascular anastomoses during a variety of surgical procedures, including coronary artery bypass grafting (CABG).
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
Corazon, Inc.
Developing proprietary technologies designed to help physicians manage calcific cardiovascular and valvular disease
during interventional and surgical procedures.
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
CryoVascular Systems, Inc.
Therapeutic devices to treat coronary artery disease.
Acquired by Boston Scientific March 2005.
160 Knowles Drive
Los Gatos, CA 95032
Tel: 408.376.3675
http://www.cryoinc.com/
|
| |
|
| |
|
| |
|
|
Cytograft Tissue Engineering
Cytograft has an innovative technology called sheet-based tissue engineering.
The goal is a tissue-engineered blood vessel as an alternative for bypass candidates
lacking the healthy native vessels required for traditional vascular reconstruction.
http://www.cytograft.com/
|
| |
|
| |
|
| |
|
|
EndoTex Interventional Systems, Inc.
Focused on developing a less invasive solution to treating carotid artery disease.
Acquired by Boston Scientific December 2006.
10231 Bubb Road
Cupertino, CA 95014
Tel: 888.336.3683
http://www.endotex.com
|
| |
|
| |
|
| |
|
Ensure Medical
|
Ensure Medical (formerly COR Medical)
Ensure Medical has developed a biodegradable, plug-based, femoral closure device.
Acquired by Cordis/JNJ June 2006.
|
| |
|
| |
|
| |
|
|
Enteric Medical Technologies, Inc.
Primary focus is the treatment of gastroesophageal reflux disease (GERD), which occurs in 40 million Americans.
Acquired by Boston Scientific June 2002.
Tel: 650.565.9814
http://www.bostonscientific.com
|
| |
|
| |
|
| |
|
|
|
| |
|
| |
|
| |
|
|
GMD
GMD was founded to manufacture, package and distribute high quality, cost effective
medical devices for standard of care procedures. GMD is initially focused on soft
tissue repair products and products used in soft tissue repair procedures. GMD's
first two products will be a universal sling kit for female stress urinary
incontinence and a complete line of ventral and inguinal hernia repair mesh. GMD'S
mission is to improve the lives of patients, families and health care providers by
offering high quality, cost effective medical devices for standard of care procedures.
|
| |
|
| |
|
| |
|
|
Hotspur Technologies, Inc.
Hotspur Technologies is the newest Incept company founded to provide innovative
solutions in the dialysis access interventional market.
|
| |
|
| |
|
| |
|
|
Intact Medical, Inc.
Developing innovative minimally invasive systems for the volumetric excision of
tissue for diagnostic and therapeutic applications
in select cancer markets. Initial products will be targeted at breast biopsy.
One Apple Hill, Suite 316
Natick, MA 01760
Tel: 888.430.4490
http://www.intactmedical.com
|
| |
|
| |
|
| |
|
Integrated Vascular Systems
|
Integrated Vascular Systems
Developing next generation proprietary vascular closure devices for use in
endovascular diagnostic and therapeutic applications.
Acquired by Abbott Laboratories September 2003.
|
| |
|
| |
|
| |
|
|
LuMend, Inc.
LuMend's products enable physicians to safely, predictably, and cost-effectively
cross chronic total occlusions in blood vessels,
and allow for subsequent treatment using catheter-based, minimally invasive procedures.
Acquired by Cordis/JNJ February 2006.
400 Chesapeake Drive
Redwood City, CA 94063
Tel: 650.364.1400
http://www.lumend.com
|
| |
|
| |
|
| |
|
|
MyoScience, Inc.
MyoScience Inc., founded in 2005 with headquarters in Redwood City, California,
is a clinical trial stage company dedicated to developing and commercializing an
innovative, hand-held medical device for use in the field of aesthetic medicine
for facial rejuvenation.
http://www.myoscience.com/
|
| |
|
| |
|
| |
|
|
Nellix, Inc.
Nellix Endovascular has developed a revolutionary endograft that will transform
the treatment of Abdominal Aortic Aneurysms (AAAs) and Thoracic Aortic Aneurysms (TAAs).
http://www.nellix.com/
|
| |
|
| |
|
| |
|
|
Oratec Interventions, Inc.
Manufactures specialized instruments for use in minimally invasive arthroscopic and spinal treatment modalities.
Acquired by Smith & Nephew February 2002.
http://www.oratec.com
|
| |
|
| |
|
| |
|
|
Paracor Surgical, Inc.
A company creating a novel device platform that will transform the treatment and
prevention of Congestive Heart Failure (CHF).
610 North Mary Avenue
Sunnyvale, CA 94085
Tel: 408.701.3250
http://www.paracorsurgical.com
|
| |
|
| |
|
| |
|
|
Point Biomedical, Inc.
Developer of a microsphere that freely circulates when injected into the bloodstream
to deliver a variety of diagnostic or therapeutic agents.
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
Promethean Surgical Devices, Inc.
PSD is a privately held biomaterials product development and manufacturing company
focused on novel minimally invasive procedures and enabling products for multiple
surgical specialties. PSD's core technology is a proprietary polymer platform that
has applications ranging from surgical adhesives to bio-benign device coatings and
injectable tissue fillers.
|
| |
|
| |
|
| |
|
Salient Interventions Inc.
|
Salient Interventions Inc.
Developing products focused on early treatment of neurologic diseases and reversal of neurologic deficits.
Status: Company out of business.
|
| |
|
| |
|
| |
|
Sapphire Medical
|
Sapphire Medical
Sapphire Medical provides new devices for shoulder repair.
Acquired by Tornier May 2007.
|
| |
|
| |
|
| |
|
Setagon, Inc.
|
Setagon, Inc
Setagon Inc. is a company developing a next-generation drug delivery system
for the emerging market of coated stents. Their technology seeks to improve on
the current polymer used for stent drug delivery by using a proprietary, metallic
nanoporous coating.
Acquired by Medtronic November 2007.
|
| |
|
| |
|
| |
|
Sinus Rhythm Technologies
|
Sinus Rhythm Technologies
Sinus Rhythm Technologies Inc treat causes of atrial fibrillation with an implanted
apparatus that creates scar tissue and blocks electrical current.
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
|
| |
|
| |
|
| |
|
|
SquareOne
Square One has developed innovative stent solutions.
|
| |
|
| |
|
| |
|
|
StemCor Systems, Inc.
Developing minimally invasive technologies to serve the emerging field of
point-of-care Regenerative Medicine. The technologies include the harvest,
processing and delivery of adult, bone marrow-derived stem cells.
|
| |
|
| |
|
| |
|
|
TheraCardia
Develop devices to increase survival rate of patients suffering from cardiac arrest, myocardial infarct and other forms of heart disease.
Technology unsuccessful. Company dissolved January 2003.
|
| |
|
| |
|
| |
|
|
Tibion Corporation
Tibion's mission is to develop smart medical devices and therapies that address
the needs of musculoskeletal and neuromuscular deficiencies.
The company is pioneering the design and development of bionic technologies which
provide non-invasive, actively-assisted mobility enhancement and rehabilitation
for those impaired by surgical recovery, stroke, aging, or loss of muscle function.
|
| |
|
| |
|
| |
|
|
TriVascular, Inc.
A medical device company developing highly advanced, innovative products for the treatment of cardiovascular disease.
Acquired by Boston Scientific February 2005.
3660 North Laughlin Road
Santa Rosa, CA 95403
Tel: 707.541.3900
http://www.trivascular.com
|
| |
|
| |
|
| |
|
